Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06286007
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-14
Brief Title:
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Sponsor:
Hospital Clinico Universitario de Santiago
Organization:
Hospital Clinico Universitario de Santiago
Study Overview
Official Title:
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRIPASCO
Brief Summary:
The main objective is to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma which will be identified by PCR for Bordetella pertussis and by PCR for RSV performed at a specific timepoint from onset of symptoms for each symptomatic Acute Respiratory Infection ARI
A multicentre prospective cohort study will be undertaken in Spain Thirty-five centres from different autonomous communities in Spain will participate in the study
Participants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up
A multicentre prospective cohort study will be undertaken in Spain Thirty-five centres from different autonomous communities in Spain will participate in the study
Participants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up
Detailed Description:
The main objective is to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma which will be identified by PCR for Bordetella pertussis and by PCR for RSV performed at a specific timepoint from onset of symptoms for each symptomatic Acute Respiratory Infection ARI
A multicentre prospective cohort study will be undertaken in Spain Thirty-five centres from different autonomous communities in Spain will participate in the study
Participants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up
Depending on the symptoms presented and date of symptom onset For pertussis patients will undergo a nasopharyngeal swab specimen for PCR if onset of the symptoms was within the past 3 weeks For RSV patients will undergo a nasopharyngeal swab specimen for PCR if onset of the symptoms was within the past 72 hours
A multicentre prospective cohort study will be undertaken in Spain Thirty-five centres from different autonomous communities in Spain will participate in the study
Participants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up
Depending on the symptoms presented and date of symptom onset For pertussis patients will undergo a nasopharyngeal swab specimen for PCR if onset of the symptoms was within the past 3 weeks For RSV patients will undergo a nasopharyngeal swab specimen for PCR if onset of the symptoms was within the past 72 hours
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None